NCT03200574 - Behavior of Valve Leaflets Following Aortic Valve Implant | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 6, 2017

Primary Completion Date

June 15, 2020

Study Completion Date

February 25, 2021

Conditions

Aortic-valve Replacement

Interventions

DIAGNOSTIC_TEST

4D Cardiac CT Scan

4D CT scan obtained at minimum of 1 month after the discontinuation of the anticoagulation or dual antiplatelet therapy

DEVICE

LivaNova Bioprothetic Aortic Valve Implant

Study includes patients that have received the commercially approved LivaNova bioprosthetic aortic heart valve Perceval, as standard of care.

Trial Locations (11)

Washington Adventist Hospital, Takoma Park

Valley Health, Winchester

Centennial, Nashville

St. Vincent Cardiovascular Research Institute, Indianapolis

Oakwood Hospital, Dearborn

Mayo Clinic, Rochester

Missouri Baptist Hospital, St Louis

Maine Medical Center, Scarborough

St. Michael's Hospital, Toronto

Montreal Heart Institute, Montreal

Universite Laval, Québec